Anti-Infective Microdose Study Aimed at MRSA. Microdosing studies were conducted to assess human PK, oral bioavailability, mass balance and distribution in skin blisters.
GSK publish on the use of AMS to determine the absolute bioavailability of dabrafenib, a BRAF inhibitor, in patients
"...AMS [is] an invaluable tool in our early drug development program, allowing us to quickly assess bioavailability in humans and focus resources on our most promising drug candidates going forward."
Find out how we can help you accelerate your drug-development program.